The Association Between Adenomyosis/Uterine Myoma and Lower Urinary Tract Symptoms

checkorphan
Learn more about:
Adenomyosis
Related Clinical Trial
Factors Associated With Adenomyosis and a Clinical Scoring System for the Diagnosis Quality of Life After Hysterectomy (AdenoQOL) Low Molecular Weight Heparin on the Adenomyosis Patients’IVF-ET Outcome Diagnosis of Adenomyosis Using Ultrasound, Elastography and MRI Clinical and Molecular Study of Endometriosis and Adenomyosis Surgical Success After Laparoscopic vs Abdominal Hysterectomy Electronic Catheter Stethoscope Ovarian Reserve Modification After Lps Hysterectomy With Bilateral Salpingectomy Does 3D Laparoscopy Improve Vaginal Cuff Suture Time? Single-port Access Laparoscopic-assisted Vaginal Hysterectomy Uterine Artery Embolization for Symptomatic Fibroids Oxytocin in MRI-HIFU To Compare to 2-channel and Multiple-channel Single Port Laparoscopic-assisted Vaginal Hysterectomy Effect of Addition of Steroids on Duration of Analgesia Paracervical Block in Laparoscopic Hysterectomy Use of Dexamethasone in Uterine Artery Embolization Treatment of Benign Uterine Disorders Using High Intensity Focused Ultrasound (MR-HIFU) Comparison of Estrogen-progestin Therapy in Continuous Regimen Versus Combination Estrogen-progestin Therapy in Continuous Regimen Plus Levonorgestrel-releasing Intrauterine System (LNG-IUS) Dienogest for Treatment of Adenomyotic Uteri Health-Related QoL Among Women Receiving Hysterectomy in NTUH Development and Validation of EHP-30 (Hong Kong Chinese Version) for Patients With Endometriosis and Adenomyosis Adenomyosis and Ulipristal Acetate Efficacy of Acupuncture on Chronic Pelvic Pain in Women With Endometriosis or Adenomyosis LNG-IUS for Treatment of Dysmenorrhea Benefit of GnRH Agonist Before Frozen Embryo Transfer in Patients With Endometriosis and/or Adenomyosis Effect of Ulipristal Acetate on Bleeding Patterns and Dysmenorrhea in Women With Adenomyosis Adenomyosis: Genomic Mechanisms and Biological Response What Are we Missing? Diagnosing Uterine Adenomyosis Using Ultrasound Elastography Comparing Efficacy of Microwave vs Embolization Treatment for Adenomyosis Role of Dienogest in the Treatment of Patient With Symptomatic Adenomyosis Comparison of the Operation and Medical Treatment of Endometriosis and Adenomyosis A Prospective Study of Diagnostic Accuracy of Ultrasound Placebo-controlled Proof of Concept Study of Epelsiban in Women With Adenomyosis A Multi-omics Study of Adenomyosis Norwegian Adenomyosis Study II: Gene Expression Profiling of Adenomyosis Levonorgestrel Intrauterine System and Adenomyosis Validation of the Adenomyosis Calculator Levonorgestrel-releasing Intrauterine System Versus a Low-dose Combined Oral Contraceptive for Management of Adenomyosis Uteri Modified Downregulation for Women With Adenomyosis of the Uterus Prior to Frozen-thawed Embryo Transfer. New Inflammation Markers for Distinguishing Uterine Adenomyosis and Leiomyoma The Association Between Adenomyosis/Uterine Myoma and Lower Urinary Tract Symptoms High-intensity Focused Ultrasound in Treatment of Uterine Adenomyosis Evaluation of Therapeutic Effect and Safety of Mifepristone in the Treatment of Adenomyosis Norwegian Adenomyosis Study III: Peristalsis Histopathological Diagnosis of Adenomyosis Norwegian Adenomyosis Study I Vaginal Bromocriptine for Treatment of Adenomyosis Levonorgestrel-releasing Intrauterine System for the Treatment of Symptomatic Adenomyosis

Brief Title

The Association Between Adenomyosis/Uterine Myoma and Lower Urinary Tract Symptoms

Official Title

The Association Between Adenomyosis/Uterine Myoma and Lower Urinary Tract Symptoms and Gastrointestinal Symptoms

Brief Summary

      The aim of this study is to assess the relationship between adenomyosis/myoma and lower
      urinary tract symptoms, sexual function and gastrointestinal symptoms.

Detailed Description

      All outpatient patients were found to have >3 cm uterine myoma or adenomyosis were invited to
      participate in this study. The size and location of uterine myoma or adenomyosis and the
      uterus should be assessed by ultrasonography. Besides, all enrolled female patients will be
      asked to complete overactive bladder symptom score, female bladder function (UDI-6 & IIQ-7),
      female sexual function index, and bowel incontinence assessment questionnaires. In addition,
      patients who underwent surgeries for myoma or adenomyosis will be requested to complete the
      above questionnaires at 3 months after surgery. Women with intact uterus should be assessed
      again by ultrasonography. At least 30 women with age and body mass index matched and without
      uterine myoma or adenomyosis will be invited to participate in this study as the control
      group.

Study Type

Observational

Primary Outcome

The corrleation coefficient between the size of myoma and Overactive Bladder Symptoms Scores

Secondary Outcome

 The corrleation coefficient between the size of myoma and the presence of constipation/diarrhea

Condition

Adenomyosis

Intervention

myomectomy or adenomyomectomy

Study Arms / Comparison Groups

 Women with uterine myoma
Description:  Women with uterine myoma

Publications

* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.

Recruitment Information

Recruitment Status

Procedure

Estimated Enrollment

150

Start Date

November 15, 2014

Completion Date

December 31, 2020

Primary Completion Date

December 31, 2020

Eligibility Criteria

        

        Inclusion Criteria:

          1. >20 years old.

          2. Myoma: women with >3 cm uterine myoma

          3. Adenomyosis: women with uterus having several dark area (lacunar areas) in one uterine
             wall or thickening uterine wall

        

        Inclusion criteria:

          1. >20 years old.

          2. Women without myoma or adenomyosis

        

        Exclusion Criteria:

          1. The patient has a lower urinary tract infection or acute intestinal inflammation.

          2. Previous surgery for the bladder or urethra.

          3. History of urinary tract stones or tumors.

Gender

Female

Ages

20 Years - N/A

Accepts Healthy Volunteers

Accepts Healthy Volunteers

Contacts

Sheng-Mou Hsiao, MD, +89667000, [email protected]

Location Countries

Taiwan

Location Countries

Taiwan

Administrative Informations

NCT ID

NCT02495311

Organization ID

103129-F

Responsible Party

Principal Investigator

Study Sponsor

Far Eastern Memorial Hospital

Study Sponsor

Sheng-Mou Hsiao, MD, Principal Investigator, Department of Obstetrics & Gynecology, Far Eastern Memorial Hospital, Banqiao, New Taipei, Taiwan

Verification Date

April 2020